ICAM1 and neoplasm: However, from a clinical perspective, free-form anti-ICAM1 antibodies may interfere with multiple intercellular interactions during tumor development and metastasis, potentially impairing normal immune functions that depend on the interaction between LFA-1/Mac-1 and ICAM-1.